Danaher Corporation Stock NYSE
Stocks
DHR PRB
US2358514097
Advanced Medical Equipment & Technology
| Market Cap | 125B 109B 101B 94.79B 178B 11,832B 179B 1,201B 466B 5,824B 471B 461B 20,222B | P/E 2026 * |
28.3x | P/E 2027 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise Value | 125B 109B 101B 94.79B 178B 11,832B 179B 1,201B 466B 5,824B 471B 461B 20,222B | EV / Sales 2026 * |
4.8x | EV / Sales 2027 * | 4.39x |
| Free-Float |
71.13% | Yield 2026 * |
0.81% | Yield 2027 * | 0.87% |
Last Transcript: Danaher Corporation
| 1 day | -0.78% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 62 | 2020-08-31 |
Matthew Gugino
DFI | Director of Finance/CFO | - | 2026-02-27 |
Steven Dee
CTO | Chief Tech/Sci/R&D Officer | - | 2025-08-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Spoon
BRD | Director/Board Member | 74 | 1999-06-30 |
Steven Rales
CHM | Chairman | 74 | 1983-12-31 |
Mitchell Rales
BRD | Director/Board Member | 69 | 1983-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +1.02% | - | - | 125B | |
| +0.63% | -2.32% | +18.35% | -13.53% | 173B | |
| +1.14% | -1.48% | -20.16% | +23.51% | 144B | |
| +0.76% | -3.99% | -55.32% | -16.62% | 67.32B | |
| +0.78% | +1.87% | +18.09% | -4.98% | 50.3B | |
| -0.58% | -0.49% | -24.84% | -35.17% | 44.09B | |
| +2.20% | -1.92% | +9.99% | +4.90% | 35.89B | |
| -0.44% | -1.20% | +4.74% | +32.04% | 34.9B | |
| +0.72% | -4.53% | -14.33% | -21.69% | 28.02B | |
| +1.26% | -1.95% | -24.81% | -13.88% | 27.24B | |
| Average | +0.56% | -2.12% | -9.81% | -5.05% | 67.16B | |
| Weighted average by Cap. | +0.49% | -1.99% | -6.95% | -2.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.13B 22.78B 21.1B 19.75B 37.04B 2,465B 37.26B 250B 97B 1,213B 98.07B 95.96B 4,213B | 28.56B 24.9B 23.06B 21.59B 40.49B 2,695B 40.74B 274B 106B 1,327B 107B 105B 4,606B |
| Net income | 4.38B 3.82B 3.54B 3.31B 6.22B 414B 6.25B 42B 16.28B 204B 16.46B 16.11B 707B | 5.53B 4.82B 4.47B 4.18B 7.84B 522B 7.89B 52.97B 20.53B 257B 20.76B 20.31B 892B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
